Zdrowie i gospodarka · 30/11/2018
FDA Requests Public Comment on Proposed Clinical Investigation Monitoring Approach
The Food and Drug Administration is seeking public input on a proposed risk-based approach to monitoring clinical investigations, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →